

KALA Bio shares surge after hours after signing an LOI to acquire a nationwide telehealth platform.
You can purchase shares of Kala Bio (NASDAQ:KALA) through any online brokerage.
Other companies in Kala Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kala Bio has a consensus price target of $39000.00.
The stock price for Kala Bio (NASDAQ: KALA) is $2.7 last updated November 20, 2026 at 7:49 PM EST.
There are no upcoming dividends for Kala Bio.
Kala Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Kala Bio.
Kala Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a...